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Abstract
Pathogen strains may differ in virulence because they attain different loads in their hosts, or because they induce
different disease-causing mechanisms independent of their load. In evolutionary ecology, the latter is referred to as
“per-parasite pathogenicity”. Using viral load and CD4þ T-cell measures from 2014 HIV-1 subtype B-infected
individuals enrolled in the Swiss HIV Cohort Study, we investigated if virulence—measured as the rate of decline
of CD4þ T cells—and per-parasite pathogenicity are heritable from donor to recipient. We estimated heritability by
donor–recipient regressions applied to 196 previously identified transmission pairs, and by phylogenetic mixed
models applied to a phylogenetic tree inferred from HIV pol sequences. Regressing the CD4þ T-cell declines and per-
parasite pathogenicities of the transmission pairs did not yield heritability estimates significantly different from
zero. With the phylogenetic mixed model, however, our best estimate for the heritability of the CD4þ T-cell decline
is 17% (5–30%), and that of the per-parasite pathogenicity is 17% (4–29%). Further, we confirm that the set-point
viral load is heritable, and estimate a heritability of 29% (12–46%). Interestingly, the pattern of evolution of all these
traits differs significantly from neutrality, and is most consistent with stabilizing selection for the set-point viral
load, and with directional selection for the CD4þ T-cell decline and the per-parasite pathogenicity. Our analysis
shows that the viral genotype affects virulence mainly by modulating the per-parasite pathogenicity, while the
indirect effect via the set-point viral load is minor.
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Introduction
The virulence of an infection is determined by both, the host
and the pathogen. One of the most common modulators of
virulence is the pathogen load. Higher load often leads to
more morbidity, or to faster disease progression or death.
Similar to virulence, the load that a pathogen strain attains
is also determined by both, the host and the pathogen. In
evolutionary ecology, hosts that limit virulence by reducing
pathogen load are called “resistant”, and pathogen strains
that attain a high load in their hosts are often termed
“virulent”.
But virulence is not completely determined by the
pathogen’s load alone. There are pathogen-load-
independent components, which are again influenced by
the host and the pathogen. A host that suffers less than av-
erage from being infected by a pathogen and carrying a spe-
cific load is called “tolerant” (Caldwell et al. 1958; Schafer 1971;
Ra˚berg et al. 2007, 2009; Boots 2008; Boots et al. 2009; Read
et al. 2008; Schneider and Ayres 2008; Little et al. 2010; Ayres
and Schneider 2012; Medzhitov et al. 2012; Ra˚berg 2014). A
pathogen strain that causes less than average virulence attain-
ing a specific load is said to have a low “per-parasite patho-
genicity” (Ra˚berg and Stjernman 2012; Ra˚berg 2014). Figure
1A displays these virulence components diagrammatically.
How can pathogen-load-independent components of vir-
ulence be determined? To identify these components, “excess
virulence” needs to be measured, that is by how much viru-
lence differs from what is expected for a specific pathogen
load. Statistically speaking, “excess virulence” is the residual
virulence after adjusting for differences in pathogen load. This
adjustment can be visualized on fitness-versus-pathogen-load
plots (fig. 1B). On such a plot, host types with differing levels
of disease tolerance are characterized by different tolerance
curves that depict the relationship between virulence and
pathogen load (see fig. 1B bottom left). The steepness of
this curve is inversely related to disease tolerance.
Once tolerance curves for different host types are deter-
mined, the per-parasite pathogenicity will manifest itself as a
yet unexplained deviation from the tolerance curve. In other
words, varying degrees of per-parasite pathogenicity will lead
to residual excess virulence that is not explained by host
factors. Figure 1C shows how two pathogen strains differing
in their per-parasite pathogenicity will scatter around the
tolerance curves of two host types.
HIV infection provides an ideal example to illustrate this
decomposition of virulence. In this infection, CD4þ T cells—
the target cells of the virus—continuously decline from a level
of 1,000 cells per microliter blood. A CD4þ T-cell count
below 200 cells per microliter blood is one of the defining
characteristics of AIDS. The decline rate of the CD4þ T cells is
a well-established surrogate for the rate of disease progression
(Phillips et al. 1991), that is virulence. It has the advantage that
it can be determined from clinical samples spanning less than
one year of monitoring an HIV infected individual, whereas
the direct observation of disease progression requires many
years. The existence of such a well-established, quantitative
measure of virulence makes HIV infection unique.
The decomposition of virulence relies on its relation with
pathogen load. During HIV infection, the viral load rises and
peaks a few weeks after infection, and subsequently settles at
a fairly stable level that is maintained for many years—the so-
called set-point viral load. This set-point viral load represents
a good measure of pathogen load required for the decompo-
sition of virulence, and it is associated with the rate of pro-
gression toward disease and death (Mellors et al. 1996).
However, the correlation between the set-point viral load
and the decline of the CD4þ T cells—a good proxy of the
rate of disease progression—is not very strong: R2 values were
found to be between 0.05 and 0.08 in American cohorts
(Rodriguez et al. 2006), and 0.05 for the population studied
here (Regoes et al. 2014) (although the correlation between
set-point viral load and survival time has been reported to be
higher, Arnaout et al. 1999). While this weak correlation may
be in part the result of measurement error it suggests that
there are factors influencing virulence other than the set-
point viral load.
In the context of HIV infection, examples for variation in all
of the four virulence components exist. First, the set-point
viral load differs by three orders of magnitude between HIV
infected individuals, ranging from 103 to 106 RNA copies per
ml plasma (Mellors et al. 1996; Raboud et al. 1996; Deeks et al.
1997). This variation is associated with the rate of disease
progression (Mellors et al. 1996). Recent heritability studies
(as reviewed in Fraser et al. 2014) have shown that a fraction
of the variation in the set-point viral load can be attributed to
the viral genotype infecting the host.
Second, human genes conferring “host resistance” in the
sense of evolutionary ecology (see above) have been identi-
fied: Individuals who carry protective HLA-B alleles have lower
set-point viral loads, and progress to disease at a slower rate
than people without these alleles (Goulder and Watkins 2008;
Fellay et al. 2007). Across primates, species-specific restriction
factors can limit the load of Human and Simian
Immunodeficiency Viruses (SIVs; Kirchhoff 2009; Zheng
et al. 2012).
Third, in the context of immunodeficiency viruses, there
are examples for variation in pathogen-load-independent vir-
ulence components. SIV infection in natural hosts, such as the
sooty mangabeys, is avirulent despite the high set-point viral
loads SIV attains in these hosts (Chakrabarti 2004; Chahroudi
et al. 2012). In contrast, SIV infection in nonnatural hosts,
such as the rhesus macaque, leads to an AIDS-like disease
(Chakrabarti 2004; Chahroudi et al. 2012). Thus, natural hosts
tolerate the infection without becoming sick. There is also
variation in tolerance to HIV infection in humans associated
with age and human leukocyte antigens (HLA; Regoes et al.
2014).
Lastly, there is also variation in per-parasite pathogenicity
across viral strains. For example, there is evidence that HIV-1
subtype D leads to faster disease progression than subtype A
even though both subtypes attain similar set-point viral loads
(Baeten et al. 2007). In other words, subtype A and D differ in
their per-parasite pathogenicity.
Previously, we investigated if humans display variation in
disease tolerance against HIV (Regoes et al. 2014). We found
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that younger individuals and HLA-B heterozygotes are more
tolerant, and could link the variation in tolerance to HLA-B
genotype. In this previous study, we did, however, not inves-
tigate the potential impact of the virus genotype on virulence.
How can one investigate if the virus genotype influences a
host–pathogen trait? One way is to study associations be-
tween genetic polymorphisms of the virus and the trait, as is
done, for example, in genome-wide association studies
(Bartha et al. 2013). An alternative approach is to estimate
the heritability of the trait. If a trait is heritable, that is similar
between similar viral genotypes, it must, at least in part, be
determined by viral genes.
The influence of the virus genotype on the set-point viral
load has been the focus of many research groups, including
ours, over the past years. Most studies determined the heri-
tability of the set-point viral load (Alizon et al. 2010;
Hollingsworth et al. 2010; Mu¨ller et al. 2011; Hodcroft et al.
2014; Fraser et al. 2014), while others investigated associations
between genetic polymorphisms of the virus and the trait
(Bartha et al. 2013). There is a consensus that set-point viral
load is heritable, although there is some controversy on the
numerical value of the heritability.
In this study, we investigate the influence of the HIV
genotype on overall virulence, as measured by the CD4þ
T-cell decline, and its pathogen-load-dependent and -in-
dependent components, the set-point viral load and per-
parasite pathogenicity, respectively. We determine the
influence of the viral genotype by estimating the
“heritability” of these traits, measuring how similar the
trait values are in the donor and in the recipient. To
this end, we use data from the Swiss HIV Cohort Study.
For our analysis, we selected cohort participants, for
whom we could determine the set-point viral load and
the decline of CD4þ T lymphocytes—an established
proxy for virulence in HIV infection. As a surrogate for
the per-parasite pathogenicity we use the residuals from
FIG. 1. Dissecting virulence. (A) Systematics of virulence components. Each component can be a trait of either the pathogen or the host, and
depend or be independent of the load of the pathogen. (B) Formally, virulence can be dissected using fitness-versus-pathogen-load plots. (In these
plots, host fitness is inversely correlated with virulence.) Adapted from figure 1 in Ra˚berg (2014). (C) In multi-host multi-pathogen systems,
virulence components can be disentangled by first defining host-type-specific tolerance curves. Pathogens differing in their per-parasite path-
ogenicity will then fall on different sides of these tolerance curves. In the example shown, pathogen B has a higher per-parasite pathogenicity than
pathogen A.
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previously determined tolerance curves (Regoes et al.
2014) as described in Materials and Methods.
Our analysis confirms that set-point viral load is heritable.
We further provide evidence the virulence of HIV infection, as
measured by the decline of CD4þ T lymphocytes, is heritable.
Lastly, we find evidence for the heritability of the per-parasite
pathogenicity, the pathogen-load-independent component
of virulence. Our results are therefore consistent with the
notion that the virus genotype affects virulence in HIV infec-
tion both via the viral load, and via viral-load-independent
mechanisms.
Results
Heritability of Set-Point Viral Load Confirmed
The heritability of the set-point viral load has previously been
estimated from data of the Swiss HIV cohort study (Alizon
et al. 2010) and from data of other cohorts (Hollingsworth
et al. 2010; Mu¨ller et al. 2011; Hodcroft et al. 2014). The
methods differed across these studies.
To test the conclusion of these studies, we applied donor–
recipient regressions and the phylogenetic mixed models to
the set-point viral loads from the 2014 individuals we in-
cluded in the present study. The donor–recipient regressions
were applied to 196 previously determined transmission pairs
(Kouyos et al. 2014), whereas the phylogenetic methods were
applied to a phylogenetic tree that was constructed from pol
gene sequences (see Materials and Methods). Since set-point
viral loads were significantly associated with sex, age at infec-
tion, and were higher in men who have sex with men, we also
estimated the heritability of adjusted set-point viral loads as
defined in Materials and Methods.
Across all the methods we use, the estimates for heritabil-
ity range from 8% to 29% (see table 1, fig. 2B and supplemen-
tary fig. S2B, Supplementary Material online). These estimates
are all significantly larger than zero, except for the adjusted
set-point viral load using the phylogenetic mixed-model that
assumes neutral evolution. These results add to the growing
consensus that set-point viral load is heritable.
Interestingly, assuming stabilizing selection on the set-
point viral load in our phylogenetic analysis led to a signifi-
cantly better fit to the data than assuming neutral drift
(Likelihood ratio test: P¼ 1.2 10–4 for unadjusted and
P¼ 8.8 10–6 for adjusted set-point viral loads). Thus, the
estimates for the heritability of the set-point viral load with
the best statistical support are 26% and 29% without and
with adjustment for cofactors, respectively. Both of these
estimates are significantly different from zero.
The optimal trait value h of the Ornstein–Uhlenbeck pro-
cess is estimated to be 104.0 RNA copies per milliliter plasma
for the unadjusted set-point viral load (95% CI: 101.6–104.3
RNA copies per milliliter plasma), very close to the mean of
the set-point viral load in our study population of 104.2 RNA
copies per milliliter plasma (see table 2). The parameter mea-
suring the strength of selection, a is high: 32.7 (95% CI: 0.03–
57.6) and 39.4 (95% CI: 6.1–68.1) for unadjusted and adjusted
set-point viral load, respectively (see table 2). These parameter
estimates are consistent with strong stabilizing selection
around the current mean trait value.
Evidence for the Heritability of CD4þ T-Cell Decline
The set-point viral load is an important determinant of CD4þ
T-cell decline, and it is heritable. We therefore expect the
CD4þ T-cell decline to be also heritable “by association”.
Table 1. Heritability Estimates for Set-Point Viral Load (spVL), CD4þ
T-Cell Decline (DCD4), and Per-Parasite Pathogenicity (ppp) Based
on the Phylogenetic Mixed Models Assuming Brownian Motion-type
Trait Evolution (PMM) or Trait Evolution According to the Ornstein–
Uhlenbeck Process (POUMM).
PMM POUMM
DCD4 (unadjusted) 25% (9%–40%) 17% (6%–29%)
DCD4 (adjusted) 24% (7%–39%) 17% (5%–30%)
spVL (unadjusted) 12% (2%–28%) 26% (8%–43%)
spVL (adjusted) 8% (0%–26%) 29% (12%–46%)
ppp 22% (5%–39%) 17% (4%–29%)
NOTE.—95% confidence intervals are given in brackets.
FIG. 2. Heritability estimates from donor–recipient regressions. For these regressions we plotted the trait values for each partner (“partner 1” and
“partner 2”) in the transmission pairs onto the x- and y-axes. Since we do not know the direction of the transmission in the pairs, the assignment of
the partners to either x- or y-axis is random. (See also supplementary fig. S2, Supplementary Material online.)
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So far, however, there has been no evidence for the heritability
of the CD4þ T-cell decline or HIV virulence.
To assess the heritability of the CD4þ T-cell decline, we
applied the same methods as for the set-point viral load.
Because the CD4þ T-cell decline was associated significantly
only with the age at infection we also conducted the analyses
with age-adjusted CD4þ T-cell declines as defined in
Materials and Methods.
The donor–recipient regression (fig. 2A) results in a heri-
tability estimate, which is not significantly different from zero
for both unadjusted and age-adjusted CD4þ T-cell declines.
This is likely the result of the low number of individuals in the
transmission pairs (2 196), which limits the statistical power
of the donor–recipient regressions.
Using the phylogenetic mixed models, however, we can
incorporate all 2014 individuals of our study population, and
obtain heritability estimates significantly larger than zero.
Assuming neutral trait evolution (PMM) yields 25% and
24% for unadjusted and adjusted CD4þ T-cell declines, re-
spectively. With trait evolution according to the Ornstein–
Uhlenbeck process we get 17% irrespective of any adjustment
(see table 1).
Again, assuming trait evolution according to an Ornstein–
Uhlenbeck process has more statistical support than
Brownian motion trait evolution (Likelihood ratio test:
P¼ 6.9 10–8 for unadjusted and P¼ 2.6 10–5 for adjusted
CD4þ T-cell declines). But, unlike for the set-point viral load,
the estimate of the optimal trait value h (-1.15 per day, 95%
CI: -2.43 to -0.29 per day) is significantly below the mean of
the CD4þ T-cell declines in our study population (-0.20 per
day), and the estimated strength of selection a is an order of
magnitude lower than that for the set-point viral load (4.1
and 3.8 for unadjusted and adjusted CD4þ T-cell decline,
respectively). See table 2 for all selection related parameter
estimates for this trait. These parameters characterize direc-
tional, rather than stabilizing selection, consistent with a slow
time trend towards higher virulence.
Evidence for the Heritability of the Per-Parasite
Pathogenicity
Lastly, we investigated if there is any evidence for the herita-
bility of the per-parasite pathogenicity. The per-parasite
pathogenicity is the component of virulence, which is deter-
mined by the pathogen genotype and independent of the
pathogen load. Formally, we determine per-parasite pathoge-
nicity by calculating the residual of the regression of the
CD4þ T-cell decline against the set-point viral load adjusted
for the age of the infected individual (see Materials and
Methods and fig. 3).
A donor–recipient regression (fig. 2C) yields an estimate,
which is not significantly different from zero, again likely due
to the low number of transmission pairs. Using phylogenetic
mixed models, we estimate a statistically significant heritabil-
ity of 22% assuming Brownian motion-type trait evolution,
and 17% for trait evolution according to the Ornstein–
Uhlenbeck process (see table 1).
As for the set-point viral load and the CD4þ T-cell decline,
assuming trait evolution governed by an Ornstein–
Uhlenbeck process led to a significantly better fit than evo-
lution according to Brownian motion (Likelihood ratio test:
P¼ 2.2 10–6). The pattern of selection most consistent
with the evolution of per-parasite pathogenicity is directional
selection as for the CD4þ T-cell decline: the optimal trait
value is estimated to be significantly lower than the popula-
tion mean, and the strength of selection is weak (see table 2).
This suggests that there is a slow time trend of increasing per-
parasite pathogenicity.
Testing for Genetic Associations with Per-Parasite
Pathogenicity
It is known that HIV-1 subtype D has a higher per-parasite
pathogenicity than subtype A. These intersubtype difference
in disease progression have been mapped to the pol gene and
were associated with replicative capacity (Ng et al. 2014). In
particular, a valine instead of an isoleucine at position 62 and
64 in the protease (I62V and I64V), and a proline instead of an
Table 2. Estimates of the POUMM Parameters Related to Selection
for Set-Point Viral Load (spVL), CD4þ T-Cell Decline (DCD4), and
Per-Parasite Pathogenicity (ppp).
a h Population
Mean
DCD4
(unadjusted)
4.1 (0.5–10.8) 1.15 (2.43, 0.29) 0.20
DCD4
(adjusted)
3.8 (0.4–10.5) 0.93 (2.30, 0.06) 0.04
spVL
(unadjusted)
32.7 (0.03–57.6) 4.0 (1.6, 4.3) 4.2
spVL
(adjusted)
39.4 (6.1–68.1) 0.03 (0.17, 0.10) 0.04
ppp 3.9 (0.5–10.4) 0.89 (2.17, 0.09) 0.00
NOTE.—95% confidence intervals are given in brackets. FIG. 3. As a surrogate for the per-parasite pathogenicity we use the
residuals from age-adjusted tolerance curves. In the graph, we plotted
each individual’s CD4þ T-cell decline versus his/her set-point viral
load. The red and blue curves show the average relationships between
these two measures in the groups that were 20 and 60-years-old at the
time of their infection, respectively. These age-adjusted tolerance
curves were determined previously (Regoes et al. 2014). The red
square and blue triangle highlight two individuals with an age at
infection of 20 and 60 years, respectively.
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alanine at position 272 in the reverse transcriptase were
found to be associated with high replicative capacity (Ng
et al. 2014).
We tested if these amino acid polymorphisms are associ-
ated with set-point viral load, CD4þ T-cell decline, and per-
parasite pathogenicity within HIV-1 subtype B. Indeed isoleu-
cine and valine at positions 62 and 64 of the protease, and
alanine and proline at position 272 in the reverse transcrip-
tase were the most prevalent amino acids in our study pop-
ulation. The set-point viral load was not associated with any
of these polymorphisms. Before adjustment for multiple com-
parisons, the association of proline at position 272 in the
reverse transcriptase with CD4þ T-cell decline and per-
parasite pathogenicity reach a significance level of P¼ 0.014
and P¼ 0.020, respectively, which is not significant after
adjusting the P-values for three comparisons.
Discussion
In this study, we confirmed the heritability of the set-point
viral load. Further, we report one of the first pieces of evidence
for the heritability of the CD4þ T-cell decline, a surrogate of
virulence. We also found support for the hypothesis that the
pathogen-load-independent virulence component is herita-
ble. Lastly, the evolution of these three traits is significantly
better described by the Ornstein–Uhlenbeck process than by
Brownian motion.
Our study confirms previous studies that established the
heritability of the set-point viral load in HIV infection (as
reviewed by Mu¨ller et al. 2011; Fraser et al. 2014). In particular,
our estimates are consistent with those from a donor–
recipient regression in Hollingsworth et al. (2010), and two
recent studies applying phylogenetic mixed models based on
the Ornstein–Uhlenbeck process by Mitov and Stadler (2016)
and Blanquart et al. (2017). Our analysis is also consistent with
the study by Hodcroft et al. (2014) that reported a low her-
itability of 5.7% of the set-point viral load adjusted for cova-
riates and assuming Brownian trait evolution. If we adjust for
covariates and assume Brownian trait evolution, we obtain a
heritability estimate of 8% that is not significantly different
from zero. Assuming trait evolution according to the
Ornstein–Uhlenbeck process, however, provides a signifi-
cantly better fit to the adjusted set-point viral load data
and yields a heritability estimate of 29%.
We find clear evidence for the heritability of the CD4þ T-
cell decline. As the level of CD4þ T cells is a defining char-
acteristic of clinical AIDS, the CD4þ T-cell decline is a good
surrogate of virulence of HIV infection. Although the poten-
tial heritability of the rate of decline of CD4þ T cells has been
investigated previously (Alizon et al. 2010), it was found to be
not significantly different from zero. We attribute this discrep-
ancy to the low sample size of the earlier study. In contrast to
the 2014 individuals in our study population, Alizon et al.
(2010) had enrolled only 1,100 and investigated the heritabil-
ity only in subpopulations consisting of a few hundred
individuals.
The recent study by Blanquart et al. (2017) also reports
heritability of the CD4þ T-cell decline. For the HIV-1 subtype
B, they estimate a heritability of 11% ranging from 0% to 19%.
This estimate is within the 95% confidence intervals of our
estimate, and our estimate of 17% is within the 95% confi-
dence intervals of their estimate. Unlike our analysis,
Blanquart et al. (2017) did not find support for the
Ornstein–Uhlenbeck over the Brownian motion trait evolu-
tion model. Their estimate of the strength of selection on the
CD4þ T-cell decline is 0.095 whereas we estimate 3.8. This
may be due to the lower sample size of 1,170 individuals in
the study by Blanquart et al. (2017). It may also be the result
of differences in the inclusion criteria: Blanquart et al. (2017)
included individuals with five CD4þ T-cell measures between
the time of their first positive HIV test and the beginning of
treatment, while we require only three CD4þ T cells but in a
more stringent time window that excludes the first 90 days
after the estimated time of infection and time points, after
the CD4þ T-cell count fell below 100 cells per microliter
blood. Differences in the tree reconstruction algorithm, how-
ever, are unlikely to explain the discrepancy. If we reconstruct
the phylogenetic tree with RaxML (Stamatakis 2006b), which
is closely related to ExaML (Kozlov et al. 2015) that Blanquart
et al. (2017) used, we obtain very similar parameter estimates
(see supplementary table S1, Supplementary Material online).
The heritability estimates based on the FastTree and RaxML
trees are most discrepant for the adjusted set-point viral load
when we use POUMM (29% vs. 34% or 38%), but, because of
the large confidence intervals, these estimates are not statis-
tically different. With the RaxML trees, we also find that
Ornstein–Uhlenbeck trait evolution has higher statistical
support.
We also provide evidence for the heritability of the per-
parasite pathogenicity. This trait describes the pathogenic
potential of a viral strain that is independent of the load
the strain attains in its host. We approximated this trait as
the deviation of the CD4þ T-cell decline observed in an in-
dividual from that predicted on the basis of the observed set-
point viral load and the age of the infected host (see Materials
and Methods). In addition to being determined by per-
parasite pathogenicity, this deviation could be affected by
further host factors, other sources of biological variation,
and, of course, measurement noise, and should therefore be
considered only as a surrogate for the per-parasite pathoge-
nicity of a strain. It is important to note, however, that the
uncertainties surrounding the quantification of the per-
parasite pathogenicity make it more difficult to establish
the heritability of this trait. The fact that we found evidence
for heritability means that the signal in our surrogate measure
of the per-parasite pathogenicity is not completely clouded
by factors, for which we could not account.
For all three traits we considered, the Ornstein–Uhlenbeck
trait evolution model has the best statistical support. For the
set-point viral load the strength of selection is estimated to be
high, and the inferred optimal value of the trait is close to the
mean of the set-point viral load in our study population.
Thus, set-point viral load is under significant stabilizing selec-
tion. The CD4þ T-cell decline and the per-parasite pathoge-
nicity, on the other hand, are not under strong stabilizing
selection but directional selection—a scenario that the
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Ornstein–Uhlenbeck trait evolution model can capture with
low selection strength a and an optimal trait value h signif-
icantly different from the population mean. The parameter
estimates of the Ornstein–Uhlenbeck model for these two
traits are consistent with a slow but significant increase in HIV
virulence over the past two decades (Pantazis et al. 2014). It is
well-recognized that the Ornstein–Uhlenbeck trait evolution
model can accommodate these two distinct patterns of selec-
tion. The difference in the nature of selection between set-point
viral load and the other two traits is also the reason behind the
bias in the heritability estimates based on Brownian motion trait
evolution: the heritability of the set-point viral load is under-
estimated, whereas those of the other two traits are slightly
overestimated. This conclusion is in agreement with simulation
studies of this bias (Mitov and Stadler 2017).
Intuitively, the heritability of the CD4þ T-cell decline
should be the combination of set-point viral load dependent
and independent components of this trait. The heritability
estimates we obtained conform surprisingly well with this
expectation. The estimate of the heritability of the CD4þ
T-cell decline with the highest statistical support is 17%.
The adjusted set-point viral load has a heritability of 29%.
To approximate to what extent the heritability of the set-
point viral load will trickle through to that of the CD4þ T-cell
decline, we need to factor in the correlation between these
two traits. In our study population, the fraction of the varia-
tion in the CD4þ T-cell decline explained by the set-point-
viral load is R2¼ 0.057, in very close agreement with estimates
of this quantity in other study populations (Rodriguez et al.
2006). Thus, 29% 0.057¼ 1.6% of the 17.4% of the heri-
tability in the CD4þ T-cell decline are due to the set-point
viral load. The remainder—16%—should be independent
of the set-point viral load. This agrees well with our estimate
of the heritability of the per-parasite pathogenicity of 17%,
especially given the uncertainty in all of these estimates.
The heritability of the per-parasite pathogenicity means
that there are viral genes that influence the CD4þ T-cell
decline in ways that do not depend on the viral load.
Generally, one conceivable such mechanism could be that
viral genotypes with high per-parasite pathogenicity elicit in-
effective immune responses that, rather than reducing viral
load, accelerate CD4þ T-cell decline. In terms of specific viral
factors influencing per-parasite pathogenicity, studies that
compare the disease course across HIV-1 subtypes are illumi-
nating. In particular, the coreceptor usage (Daar et al. 2007)
and pol replicative capacity (Barbour et al. 2004; Goetz et al.
2010; Ng et al. 2014) have been found to be associated with
the rate of disease progression independently of the set-point
viral load. Ng et al. (2014) identified three amino acid poly-
morphisms that are associated with replicative capacity. We
tested if these polymorphisms are associated with per-
parasite pathogenicity, CD4þ T-cell decline and set-point
viral load. While we could not establish any clear-cut associ-
ation after adjusting for multiple comparisons, a proline at
position 272 of the reverse transcriptase was the most prom-
ising candidate. The sample size for this test was lower
(n¼ 1222) than the size of our study population
(n¼ 2014) because the sequence region containing position
272 in the reverse transcriptase was not available in all indi-
viduals. This polymorphisms should be tested in the future for
an association with CD4þ T-cell decline and per-parasite
pathogenicity in a larger study population.
Previously, Pagel’s k was also employed to estimate the
heritability of the set-point viral load from a phylogenetic tree
of HIV pol sequences (Alizon et al. 2010). Leventhal and
Bonhoeffer (2016), however, have argued recently that
Pagel’s k implicitly assumes the trees to be ultrametric.
Thus, for nonultrametric phylogenetic trees, such as the
one we analyzed, this essential assumption of Pagel’s k is
violated, and this method should therefore not be used.
We nevertheless provide heritability estimates for comparison
in supplementary figure S1, Supplementary Material online.
With Pagel’s k the set-point viral load and the CD4þ T-cell
decline are also found to be significantly heritable.
The heritability of traits from donor to recipient is some-
times interpreted as the quantitative measure of the extent to
which the trait is “under the control of the virus”. It has been
pointed out that the viral genome carries an imprint of past
environments, in particular the immune responses experi-
enced in former hosts (Bartha et al. 2013, 2017; van Dorp
et al. 2014; Carlson et al. 2014 2016). Thus, separating virus
from host effects is challenging. What is undisputed is that
the trait in the new host is in part encoded in the viral ge-
nome. Information on associations with viral genes is very
valuable, especially for traits that cannot be determined in-
stantaneously, such as the CD4þ T-cell decline.
In summary, we presented a comprehensive evolutionary
analysis of the components of HIV virulence. We established
that viral load dependent and independent virulence com-
ponents, as well as overall virulence are heritable. This strongly
suggests that these virulence components are, at least in part,
encoded in the viral genome. Future research will need to
identify the specific genetic polymorphisms associated with
these virulence components.
Materials and Methods
Study Population
We analyzed a subset of the individuals from the Swiss HIV
Cohort Study (www.shcs.ch; last accessed September 24,
2017; Schoeni-Affolter et al. 2010). This study has enrolled
>19,000 HIV-infected individuals to date, which constitutes
>72% of all patients receiving antiretroviral therapy in
Switzerland, and is therefore highly representative. The viral
load and CD4þ T-cell count of each enrolled individual are
determined approximately every three months. In some of
these individuals, the pol gene of the virus was sequenced.
The pol gene encodes viral enzymes important for viral rep-
lication within its target cell, most notably the reverse tran-
scriptase, the integrase, and the protease, and contains many
of the clinically relevant resistance mutations.
The study population of the present study consists of a
subset of the study population analyzed in a previous study
(Regoes et al. 2014). In this previous study, we had included
3,036 HIV-1 infected individuals, for whom viral load meas-
urements and CD4þ T-cell counts were available to reliably
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estimate the set-point viral load and CD4þ T-cell decline. We
restricted our analysis to data obtained before antiretroviral
treatment. Furthermore, we excluded the primary and late
phases of the infection by discarding measurements during
the first 90 days after the estimated date of infection and
measurements obtained when the CD4þ T-cell count was
below 100 per microliter blood. Lastly, individuals were in-
cluded if they had at least two viral load measurements and
three CD4þ T-cell measurements that were at least 180 days
apart.
For the present study, we selected 2014 individuals of the
3,036 individuals enrolled previously. Individuals were in-
cluded if the pol gene of their virus had been sequenced.
The genetic information of the virus was necessary for the
present study to infer the evolutionary history and investigate
patterns of heritability.
Pol sequence information was obtained from the SHCS
genotypic drug resistance database. Sequences are stored in
a central database (SmartGene; Integrated Database Network
System version 3.6.13). All laboratories perform population-
based sequencing (von Wyl et al. 2007; Yang et al. 2015). The
drug resistance database includes, in addition to the routinely
collected samples, over 11,000 samples from the biobank an-
alyzed by systematic retrospective sequencing (Yang et al.
2015; Schoeni-Affolter et al. 2010). The individuals in our
study population belong to the following risk groups: men
having sex with men—972 (48%), heterosexuals—435
(21.5%), intravenous drug users—365 (18%), and others—
252 (12.5%).
The SHCS, enrolling HIV-infected adults aged over 16-
years-old, has been approved by ethics committees of all
participating institutions. The data collection was anonymous
and written informed consent was obtained from all partic-
ipants (Schoeni-Affolter et al. 2010).
Set-Point Viral Loads and CD4þ T-Cell Declines
For each individual enrolled in our study, the set-point viral
load had been determined in a previous study (Regoes et al.
2014) as the mean of the logarithm to the base 10 of the
eligible viral load measurements in each individual.
Nondetectable viral loads had been set to half the detection
limit. The rate at which the CD4þ T cells change per day had
previously been estimated as the slope in a linear regression of
CD4þ T-cell counts in an individual against the date, at which
they were determined. The rate of change in CD4þ T cells is
inversely related to virulence.
Set-point viral loads and CD4þ T-cell declines were ad-
justed for potential covariates by regressing them against sex,
age at infection, risk group and ethnicity. Once significant
covariates were identified, adjusted traits were defined as
the residuals of a regression with these covariates.
Subsequent analyses were then conducted with the residuals.
The inclusion criteria, calculation of set-point viral load
and CD4þ T-cell decline, as well as the model fitting and
comparisons had been implemented and performed in the R
language of statistical computing (R Core Team 2013).
Per-Parasite Pathogenicity
Per-parasite pathogenicity is defined as the pathogenic po-
tential of a pathogen strain adjusted for its load and host
factors that are associated with pathogen-load independent
virulence components.
To derive a proxy for the per-parasite pathogenicity of a
strain, we first determined the relationship between pathogen
load and pathogenicity—called the tolerance curve—for a given
host type. In our previous study (Regoes et al. 2014), we found
that the age, at which the host was infected, was associated very
strongly with the slope of the tolerance curve. Therefore, we
determined the tolerance curve specific for the age of the host
that harbors the pathogen strain. We did not account for host
factors other than age, such as, for example, HLA-B genotype or
homozygosity, because this information of host genotype is
lacking for the majority of our study population.
In a next step, we predicted the CD4þ T-cell decline we
should observe given the set-point viral load that this strain
attains in the host. Lastly, we calculated by how much the
observed CD4þ T-cell decline deviates from this prediction
(see fig. 3).
In our conceptualization, tolerance is measured by the
parameter characterizing the relationship between the
CD4þ T-cell decline and the set-point viral load. Different
levels of per-parasite pathogenicity, on the other hand, man-
ifest themselves as a deviation of an individual’s CD4þ T-cell
decline and set-point viral load from the tolerance curve.
Formally, this procedure amounts to regressing CD4þ T-
cell decline against the set-point viral load, adjusting for the
age at infection, and calculating the residual of an individual’s
trait from the regression line. We denote this proxy as ppp.
Lower and more negative values of this quantity are associ-
ated with faster disease progression.
Transmission Pairs and Phylogenetic Tree
The transmission pairs were identified as monophyletic clus-
ters on a previous HIV transmission tree (Kouyos et al. 2014).
Of these previously established transmission pairs, 196 were
present in our study population. The direction of transmis-
sion cannot be inferred in these pairs.
The reconstruction of the phylogenetic tree relies on pol
gene sequencing of the virus carried by the study subjects. In
particular, we had sequences of pol extending over the HXB2
positions 2253–3870, comprising the protease and the reverse
transcriptase. All sequences were initially aligned to an HXB2
reference genome (http://www.ncbi.nlm.nih.gov/nuccore/
K03455.1; last accessed September 24, 2017) using MUSCLE
(Edgar 2004). We selected the earliest sequence if more than
one sequence was available for a person.
To reconstruct the evolutionary history, we first removed
insertions relatively to HXB2. To exclude signatures of parallel
evolution due to drug pressure that can distort the inferred
evolutionary history, we further removed drug resistance
mutations according to the databases of Stanford (http://
hivdb.stanford.edu/; last accessed September 24, 2017) and
the International Antiviral Society (https://www.iasusa.org/;
last accessed September 24, 2017). We used Gblocks to refine
the alignment. The final number of positions was 1106.
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We constructed the phylogenetic tree using FastTree
(Version 2.1.8 SSE3, OpenMP; Price et al. 2010). We used a
maximum-likelihood-based inference using a Generalized
Time-Reversible evolutionary model and a CAT model
(Stamatakis 2006a) with 20 discrete evolutionary rate catego-
ries. We use the most rigorous and time-consuming FastTree
parameters (FastTreeMP -pseudo -spr 4 -mlacc 2 -slownni -
gtr -nt). We rooted the tree with 10 Subtype C sequences as
an outgroup, using the R package APE. The branch lengths in
our tree correspond to genetic distances between the sequen-
ces, and not to time.
We also compared the results obtained from this tree with
those of two trees reconstructed with RaxML (Stamatakis
2006b). These trees were reconstructed assuming a
Generalized Time-Reversible evolutionary model. One as-
sumed CAT model with 25 discrete evolutionary rate cate-
gories, the other C-distributed evolutionary rates.
Supplementary table S1, Supplementary Material online,
shows that there is generally good agreement between the
results.
Heritability Estimation
To estimate the heritability of the three traits—set-point viral
load, CD4þ T-cell decline and per-parasite pathogenicity—
we used two approaches.
First, we applied donor–recipient regressions that are for-
mally equivalent to parent-offspring regressions (Fraser et al.
2014) to the 196 previously identified transmission pairs.
Although we do not have any information on the direction
of transmission in these pairs, we expect that a regression
between the trait in question will yield a good estimate of the
heritability (Bachmann et al. 2017).
Second, we employed phylogenetic mixed models
(Housworth et al. 2004) that are widely used to estimate
the heritability from a phylogenetic tree. These methods
have the advantage of being able to incorporate larger study
populations and transmission relationships ranging from
close pairing to distant epidemiological linkage. We used
the recent implementation by Leventhal and Bonhoeffer
(2016) in the R language of statistical computing (R Core
Team 2013). The models that underlie this method assume
trait evolution according to Brownian motion, meaning that
traits drift neutrally. Brownian motion is characterized by the
diffusion constant which is related to the heritability. Because
we use the method on a tree, the branch lengths of which
correspond to genetic distances, we make the implicit as-
sumption that heritability increases linearly with genetic dis-
tance. Previous studies used Pagel’s k to estimate heritabilities
(Alizon et al. 2010; Shirreff et al. 2013). We refrained from
using Pagels k in our main analysis because it is not as ap-
propriate as phylogenetic mixed model for nonultrametric
trees (as our phylogenetic tree; Leventhal and Bonhoeffer
2016). However, as a point of comparison with estimates of
Pagels k in previous studies, we report our estimates of this
quantity in the supplementary material, Supplementary
Material online.
We also applied phylogenetic mixed models based on the
Ornstein–Uhlenbeck process that describe stabilizing trait
selection around an optimal trait value rather than neutral
drift. In addition to the diffusion constant, this model has a
parameter for the trait value around which selection stabilizes
the trait, h, and another parameter describing the strength of
selection, a. In macroevolutionary applications, the parameter
a is often translated into a characteristic time t1=2¼ ln(2)=a
needed for the trait to evolve halfway back to its optimum
(Hansen 1997). The heritability in POUMM is related to all
three parameters of the Ornstein–Uhlenbeck process (Mitov
and Stadler 2016). We used the implementation by Mitov
and Stadler (2017).
Testing for Genetic Associations with Per-Parasite
Pathogenicity
Previous studies identified a valine instead of an isoleucine at
position 62 and 64 in the protease (I62V and I64V), and a
proline instead of an alanine at position 272 in the reverse
transcriptase as amino acid substitutions that could be asso-
ciated with per-parasite pathogenicity (Ng et al. 2014) (see
the Result section for more details). To test for associations of
per-parasite pathogenicity with the substitutions I62V, I64V,
and A272P, we regressed per-parasite pathogenicty, but also
the other two traits, set-point viral load and CD4þ T cells
decline, against categorical variables indicating the presence
of the mutated amino acid at the respective position. The
mutated amino acids were defined as a valine in position 62
and 64 of the protease, and a proline in position 272 of the
reverse transcriptase. In these regressions, we also included
cofactors such as age, sex and risk group.
An association with per-parasite pathogenicity was
assessed in two ways. First, we regressed the proxy for per-
parasite pathogenicity defined above—residuals from the
age-adjusted tolerance curves—against the presence of the
substitute amino acid. Second, we regressed the rate of
change in the CD4þ T cells against the square of the loga-
rithm to the base of 10 of the set-point viral load, including
the presence of the mutated amino acid at the respective
position as an interaction term. We also included the sex and
age at infection as cofactors in the analysis:
DCD4 ¼ða0 þ g62PROT:V þ g64PROT:V
þ g272RT:P þ gM þ c aÞðlog10VÞ2 þ 
(1)
Here, DCD4 denotes the rate of change in the CD4þ T-cell
level per microliter blood per day. The parameter a0 describes
the relationship between set-point viral load and CD4þ T
cells decline for females with age zero that are infected with a
virus that does not express any of the mutant amino acids
we consider. The remaining parameters describe the offset
that can be attributed to the various cofactors:
g62PROT:V; g64PROT:V , and g272RT:P describe the potential
change in the relationship between set-point viral load and
CD4þ T-cell decline due to each considered amino acid sub-
stitution, and gM quantifies the change due to being male. ca
is the offset to a0 in an individual of age a. This procedure
follows the approach we have adopted previously to test for
the association of host factors with disease tolerance (Regoes
et al. 2014).
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Supplementary Material
Supplementary data are available at Molecular Biology and
Evolution online.
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